A B S T RA C T In 12 dogs anesthetized with chloralose, angiotensin (angiotensin II amide) given intravenously increased the glomerular filtration rate (GFR) of an ischemic kidney while simultaneously having little effect on the GFR of the contralateral kidney. In the ischemic kidney, in 14 of 30 observations, increments of GFR greater than 100% of mean control GFR (9 ml/min) occurred in response to angiotensin. The magnitude of the increase in GFR produced by angiotensin was independent of dose (range 0.005-0.050 jug/kg per min), the degree of accompanying pressor response, and alterations in renal blood flow (RBF) (electromagnetic flowmeter). In the ischemic kidney, increments of GFR could be produced by sub-pressor doses of angiotensin.
INTRODUCTION
The renin-angiotensin system has been proposed to regulate glomerular filtration rate (GFR) (1, 2) . The privileged location of the juxtaglomerular apparatus at the vascular pole of the glomerulus suggested to Goormaghtigh that it participated in regulating glomerular blood flow (3) . In relating activity of the renin-angiotensin system to the control of GFR, assignment of the dominant action of angiotensin1 to the pre-or postglomerular arteriole is a necessary first step. Thus, a primary action of angiotensin on the postglomerular arteriole was proposed by Schmid (1) and Leyssac (4) . In contrast, Thurau considers the preglomerular arteriole to be the dominant site of action of angiotensin, thereby regulating the tubular load of sodium (2) . GFR is usually reduced in response to doses of angiotensin II having moderate pressor effects (5) . Predictable increases of GFR in response to angiotensin II have not been shown.
The observation of the attenuation or loss of the renal vasoconstrictor action of angiotensin II during renal ischemia (6) suggested to us that the effect of angiotensin II on GFR may be altered in a similar manner. This consideration may be relevant to the proposals that angiotensin participates in the regulation of GFR.
The experiments reported in this paper demonstrate that the effect of angiotensin II on GFR was dependent on the control level of GFR. Thus, angiotensin II administered during renal ischemia invariably increased the depressed GFR of the ischemic kidney, while simultaneously, having no effect or decreasing the GFR of the contralateral kidney. If mannitol was administered, a natriuresis occurred a) as an initial response to renal arterial constriction (RAC) in the contralateral kidney, and b) in the ischemic kidney in responise to angiotensin II during RAC.
METHODS
Twelve male mongrel dogs weighing from 19 to 26 kg were anesthetized with morphine sulfate (2 mg/kg, subcutaneously) and chloralose (100 mg/kg, intravenously). The abdominal cavity was entered through a transverse incision. The renal arteries were dissected free; care was taken not to disturb their innervation. A polyethylene catheter was introduced in a retrograde direction into each ureter and secured in place at the ureteropelvic junction. The dead space of each catheter was less than 1.1 ml. A multichannel direct writer (Sanborn Co., Waltham, Mass.) was used to record mean aortic blood pressure (MABP) as measured by a transducer (model P23Db, Statham Instruments, Inc., Los Angeles, Calif.) via a catheter inserted in a retrograde direction into a femoral artery, and renal blood flow (RBF) as measured by electromagnetic flowmeters (Statham model M-4001). Electromagnetic flowmeter sensors with openings of 2.5-3.5 mm, selected according to the size of the artery, were placed on each renal artery. The flowmeters were calibrated in two ways: perfusing blood through an excised renal arterial segment, and collecting femoral arterial blood for timed intervals while observing changes on the electromagnetic flowmeter with the flowmeter sensor placed proximal to the collecting site. The two methods for calibrating flowmeters were used for each sensor and were shown to agree within 5%o. Previously Since MABP (mean aortic blood pressure) and RBF were continuously recorded, any departure from the steadystate was immediately apparent The clearance period was unacceptable, if changes in RBF (> 10%) occurred after allowing stabilization when the renal artery was constricted or angiotensin II was infused. Because of the minimal dead space (< 1.1 ml/kidney) and continuous monitoring of MABP and RBF, the accuracy of the clearance periods was of a high order.
The data were transformed to natural logarithms to achieve approximate normality because the data appeared to be skewed and the standard deviation usually increased with the mean. A computer program was used in the analysis of variance for each response in a three-way classification: kidney, dog, and time. Because the interaction of treatment by kidney was significant, the data on each kidney were then analyzed separately by using an analysis of vasoconstriction which were indistinguishable from those occurring in dogs receiving glucose.
In Fig. 2 , the effects of angiotensin II on MABP, RBF, GFR, and UNNV (average of two or three periods for the latter two parameters) of the separate kidneys before, during, and after constriction of the right renal artery are shown. Angiotensin II produced a differential effect on GFR during RAC; the GFR of the ischemic kidney was increased while that of the contralateral kidney was reduced. Sodium excretion increased bilaterally in spite of concomitant reductions in RBF. After release of the arterial constriction, angiotensin II reduced UNaV bilaterally relative to the values obtained in the period of recovery.
In five of the six experiments in which 10%, mannitol in 0.3% saline was given, after release of the arterial constriction, recovery observations were made and the infusion of angiotensin II (0.025 ,ug/kg per min) was repeated (Table III) . Angiotensin II increased MABP, reduced RBF, and produced an antinatriuresis in the postconstriction period which are the expected responses to this dose of angiotensin II in dogs (5).
For dogs receiving mannitol, there was no correlation between the magnitude of changes in GFR and the magnitude of changes in UNaV for ischemic (r = 0.334) or contralateral kidneys. Moderate to large increases in UNaV occurred in association with variable increases in GFR in the ischemic kidney, in contrast to those experiments in which 5% glucose in water was given.
Comparable increases in UNaV occurred less frequently in the contralateral kidney. However, the mean values for UNaV preceding infusion of angiotensin II differed significantly; viz., 85.5 and 10.9 1LEq/min for contralateral and ischemic kidneys, respectively (Table II) . GFm An analysis of covariance adjusting changes in UNaV for changes in GFR showed no significant differences between the ischemic and contralateral kidneys. However, the ischemic and contralateral kidneys of each group (those receiving glucose or those receiving mannitol) could be differentiated on the basis of changes in GFR produced by angiotensin II (P < 0.01). The GFR of the ischemic kidney increased consistently, but showed little change and then usually a reduction in the contralateral kidney in each group (Fig. 3) . The effects of angiotensin II on the simultaneously determined GFR of ischemic and contralateral kidneys for all 12 experiments (30 observations) are shown in Fig. 3 . The changes in GFR produced by angiotensin II in the contralateral or ischemic kidneys during infusion of 10% mannitol in 0.3%, saline were similar to those changes in GFR observed when 5% glucose in water was administered; viz., increased GFR to the ischemic kidney and variable effects on GFR of the contralateral kidney. The changes observed in GFR in the ischemic kidney were much greater than could be accounted for by an error inherent in the anthrone method for measuring inulin (9) . Thus, the standard error (obtained from the mean square for the residual in the analysis of variance) for the measurement of GFR was less than 2.5%. The capacity of angiotensin II to increase GFR in the ischemic kidney was most readily demonstrated when the GFR was reduced below 15 ml/min. On two occasions, when RAC resulted in a GFR which was within the range of GFR for the contralateral kidneys (20-30 ml/min), angiotensin II produced changes in the GFR similar to those observed in contralateral kidneys (Fig. 3) . The coincident effects of angiotensin II on the GFR of the contralateral kidney were variable: moderate reductions of GFR were noted in 18 of 30 observations. The effects of angiotensin II on the simultaneously determined GFR for ischemic and contralateral kidneys were significantly different when the data were pooled (P <0.001), or when considered with respect to dose; viz., P 
DISCUSSION
Angiotensin II was shown in the present experiments to increase the GFR of an ischemic kidney while having variable effects on the GFR of the contralateral kidney. This differential effect of angiotensin II on GFR during unilateral renal ischemia occurred independently of consistent changes in aortic blood pressure, RBF, sodium excretion, plasma sodium, and hematocrit. The magnitude of the increase in GFR produced by angiotensin II in the ischemic kidney was independent of the dose (within the range of 0.005-0.050 ug/kg per min), the degree of the accompanying pressor response, and altered renal vasoconstrictor activity of angiotensin II (Table I ). The present experiments dissociate increments in GFR from simultaneous increases in sodium excretion. Thus, when 5% glucose in water was administered, in spite of a mean increase in GFR of 100% produced by angiotensin II, a coincident increase in sodium excretion did not occur. Furthermore, when a natriuresis oc-FIGURE 3 Relation between increments in glomerular filtration rate (A GFR) and control GFR for all experiments (30 observations in 12 dogs) for the simultaneously determined GFR of ischemic and contralateral kidneys in chloralose-anesthetized dogs. The dose of angiotensin II is expressed in ,ug/kg per min. Dogs receiving 5% glucose in water are undesignated. Mannitol refers to the dogs receiving 10% mannitol in 0.3%o saline.
curred in response to RAC and angiotensin II in the dogs receiving mannitol, the increment of GFR was unrelated to the degree of coincident natriuresis. Lindheimer, Lalone, and Levinsky have dissociated increases in GFR from increases in sodium excretion (11) . Angiotensin II increased the GFR of the ischemic kidney independently of simultaneous changes in MABP and RBF. In two experiments, increases of GFR of 7 and 8 ml/min occurred (> 100% of control GFR) within the ischemic kidney in response to a subpressor dose of angiotensin II (0.005 ug/kg per min). Furthermore, increments in GFR were not correlated with the magnitude of the accompanying pressor response to angiotensin II. While only increases in GFR occurred in the ischemic kidney in response to the lower doses of angiotensin II, variable changes in blood flow occurred. In response to the higher doses of angiotensin II (0.025 and 0.050 pug/kg per min), in spite of large reductions in RBF, increases in the GFR of the ischemic kidney occurred which were similar to those produced by the lower dose (Tables I and II) .
The afferent and efferent glomerular arterioles are the major vascular resistance sites in the renal vascular tree, since the greatest dissipations of hydrostatic pressure occur: a) between the renal arteries and the glomerular capillaries (afferent arteriolar resistance site), and b) between the glomerular capillaries and peritubular capillaries (efferent arteriolar resistance site) (12) . The contribution of the preglomerular arteriole to the regulation of GFR is conspicuous when renal perfusion pressure is markedly increased by hypertension (13) . To maintain a constant GFR, a degree of independence of the glomerular arterioles would be required in their response to conditions having such disparate effects on intrarenal hemodynamics as essential hypertension, renal arterial stenosis, and hypovolemia.
The determinants of the dominant site of vasoconstrictor action (pre-or postglomerular) of angiotensin II remain to be defined. A preferential effect of angiotensin II on either pre-or postglomerular arteriolar resistance may be modulated by the sympathetic nervous system in which fibers invest the juxtaglomerular apparatus and the vascular pole of the glomerulus (14) . The interaction of renal adrenergic nerves and angiotensin II was considered to be a determinant of the renal vascular and natriuretic effects of angiotensin II (8, 15) .
Thurau proposed a dominant preglomerular action of angiotensin to adjust the tubular sodium load to the tubular reabsorptive capacity for sodium (2) . However, this hypothesis fails to account for the increased release of renin which occurs immediately on reducing renal arterial pressure, at which time a reduced sodium load has the same effect as Thurau proposed for an increased sodium load (2, 16) . The major effect of angiotensin II when infused intravenously is presumably registered on the postglomerular arteriole since filtration fraction consistently increased (17) . A dominant postglomerular action of endogenous angiotensin was suggested on the basis of failure to maintain GFR when the efferent glomerular arteriolar tone was reduced. Thus, dogs, having a high titer of antirenin, were shown to have a reduced capacity to adjust to decreased postglomerular resistance as reflected in a reduced GFR (1) .
The increase in GFR of the ischemic kidney, and its relative constancy in the contralateral kidney, is consistent with an increase primarily in postglomerular arteriolar tone, in view of the large reductions in RBF produced by angiotensin II at doses of 0.025 and 0.050 ug/kg per min. This consideration does not exclude a simultaneous lesser increase or even reduction in afferent glomerular arteriolar tone. The alternate hypothesis of primary dilation of the afferent arteriole (and accompanying constriction of the efferent arteriole) by angiotensin II within the ischemic kidney challenges a large body of work demonstrating that a vasoconstrictor action, presumably of physiologic significance, is a fundamental property of this polypeptide (18) . Attenuation of the vasoconstrictor action of angiotensin II during renal ischemia was described, but a direct renal vasodilator action has not been demonstrated (6) . The suggested locus of action of angiotensin II under these experi-mental conditions does not exclude a dominant preglomerular action under other conditions. Physiologically, the vascular activity of angiotensin is partially defined by the site of its activation, i.e., somewhere between the points of release of renin from the afferent arteriole and the vascular tree downstream. Ng and Vane have shown that the major conversion of angiotensin I to II required passage through the pulmonary circulation (19) , The implications of this important observation relative to dominant intrarenal sites of action and differences in the effects of the two angiotensins remain to be determined.
A natriuresis occurred in the dogs receiving mannitol as an initial response of the contralateral kidney to RAC and in the ischemic kidney in response to angiotensin II (Table II) . The natriuresis produced by angiotensin II did not require for its demonstration a pressor response, blunting of its renal vasoconstrictor action, or altered filtration fraction, for similar changes in these parameters occurred irrespective of simultaneous changes in sodium excretion. While an increased blood pressure may have facilitated the demonstration of a natriuresis in response to angiotensin II, it could not have contributed to the natriuresis of the contralateral kidney induced initially by RAC since the latter was not accompanied by a pressor response. The two interventions producing natriuresis, RAC and angiotensin II in the dogs receiving mannitol, were each associated with reductions in RBF. Furthermore, blunting of the renal vasoconstrictor effect of angiotensin II by mannitol which has been reported did not occur (20) . In the dogs receiving the lower doses of angiotensin II, the frequent occurrence of increased blood flow to the ischemic kidney did not result in natriuresis (Table I ). An increased filtered load of sodium did not account for the natriuresis produced by angiotensin II since the greater concentration of plasma sodium of the group receiving mannitol was more than offset by their diminished GFR. Mannitol was reported to reduce GFR by increasing proximal intratubular pressure (21) .
Changes in plasma sodium may have been a determinant of the failure of angiotensin II to produce natriuresis in the dogs receiving glucose (Table I ). This factor could not account for the natriuresis in the dogs receiving mannitol since plasma sodium remained constant throughout the experiments. The role of altered plasma sodium concentrations in modifying sodium excretion is uncertain. An inverse relationship was reported between plasma concentration of sodium and its reabsorption (22, 23) . However, Martino and Earley considered the effect of the sodium ion on tubular transport to be related rather to accompanying intratubular volume effects (24) . The natriuretic effect of angiotensin II in the rat was reported to be dependent upon expansion of the extracellular space (25) and abolished in the presence of diuresis invoked by water loading (26) . Expansion of the extracellular space, though it may have been contributory, was not a major determinant of the natriuresis produced by RAC and angiotensin II. Thus, in the dogs, not demonstrating a natriuresis to angiotensin II, expansion of the extracellular space was probable, for plasma sodium showed a progressive reduction in the face of an antidiuresis (Table I) . If this factor were a determinant of the natriuresis produced by angiotensin II in the dogs receiving mannitol, it was later nullified, for release of the RAC resulted in a restoration of the antinatriuretic action of angiotensin II (Table III) .
The effects of mannitol in revealing a natriuresis in response to RAC and angiotensin II may have operated through its effect on proximal tubular reabsorption of sodium (27) which then allowed the demonstration of a natriuresis to either administered angiotensin II or endogenous angiotensin by increasing delivery of sodium to the distal nephron. Angiotensin also may have an effect on proximal tubular reabsorption of sodium (4, 28) . Thus, Earley and Friedler reported a natriuresis in response to angiotensin II during induction of renal vasodilation by acetylcholine and bradykinin (28) . They suggested that the natriuresis resulted from facilitated transmission during vasodilation of the pressor effect of angiotensin II to the postglomerular capillaries, thereby secondarily influencing proximal tubular reabsorption of sodium. A distal tubular action (though not exclusive) of angiotensin II was proposed by several investigators (29) (30) (31) . A proximal tubular action of angiotensin II, while not necessary for this consideration, if it occurred, would have facilitated the effects of mannitol. However, this hypothesis neither explains the antinatriuresis produced by angiotensin II (postconstriction) in these same experiments, nor does it encompass the effects of RAC on the initial natriuresis from the contralateral kidney (before giving angiotensin II) unless the effects of increased circulating levels of endogenous angiotensin produced this effect on the contralateral kidney (Tables II and III) . Renin release and presumably formation of angiotensin are known to occur rapidly after induction of renal ischemia (32) .
We must conclude that the induction of RAC has modified the response to mannitol and angiotensin by introducing (eliminating) a factor(s) which awaits definition. Unilateral RAC in rats was reported to alter the natriuretic response to angiotensin II in the contralateral kidney, if hypertension was induced, and in the clipped kidney, if hypertension did not develop (33, 34) . The present experiments cannot exclude intrarenal hemodynamic or extrarenal humoral factors acting in concert with or independently of angiotensin to produce natriuresis during renal ischemia in dogs receiving 10% mannitol in 0.3% saline (35) .
